How an Early Bet on Innovation Is Changing the Cancer Care Experience

On Advancing Medical Innovation Through Sustained Support

Bryan Weingarten’s support of academic medicine has extended beyond institutional involvement to directly enabling research with lasting, real-world impact. Through targeted funding provided several years ago, Bryan helped support the work of Dr. Erin Bange on a research initiative addressing “time toxicity” for cancer patients—a concept focused on reducing the hidden burdens patients face as they navigate care.

That early support has since resulted in the publication of research in the New England Journal of Medicine’s Catalyst section, which highlights innovation in healthcare delivery. The study explores how a text message–based tool can help address time toxicity, offering a practical, patient-centered approach to improving the cancer care experience. The publication reflects not only the strength of the research, but the long-term value of investing in ideas at an early stage.

For Bryan Weingarten, this outcome reflects a broader philosophy of engagement—supporting medical research that is thoughtful, innovative, and focused on improving patient experience over time. The continued impact of this work illustrates how early investment in promising ideas can resonate years later, shaping care practices and contributing to the evolving landscape of healthcare innovation.